Multivariable models for advanced colorectal neoplasms in screen-eligible individuals at low-to-moderate risk of colorectal cancer: towards improving colonoscopy prioritization.

Clinical prediction rule Colonoscopy Colorectal cancer Multivariable prediction model

Journal

BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547

Informations de publication

Date de publication:
18 Oct 2021
Historique:
received: 28 04 2021
accepted: 07 10 2021
entrez: 19 10 2021
pubmed: 20 10 2021
medline: 21 10 2021
Statut: epublish

Résumé

Advanced colorectal neoplasms (ACNs), including colorectal cancers (CRC) and high-risk adenomas (HRA), are detected in less than 20% of persons aged 50 years or older who undergo colonoscopy. We sought to derive personalized predictive models of risk of harbouring ACNs to improve colonoscopy wait times for high-risk patients and allocation of colonoscopy resources. We characterized colonoscopy indications, neoplasia risk factors and colonoscopy findings through chart review for consecutive individuals aged 50 years or older who underwent outpatient colonoscopy at The Ottawa Hospital (Ottawa, Canada) between April 1, 2008 and March 31, 2012 for non-life threatening indications. We linked patients to population-level health administrative datasets to ascertain additional historical predictor variables and derive multivariable logistic regression models for risk of harboring ACNs at colonoscopy. We assessed model discriminatory capacity and calibration and the ability of the models to improve colonoscopy specificity while maintaining excellent sensitivity for ACN capture. We modelled 17 candidate predictors in 11,724 individuals who met eligibility criteria. The final CRC model comprised 8 variables and had a c-statistic value of 0.957 and a goodness-of-fit p-value of 0.527. Application of the models to our cohort permitted 100% sensitivity for identifying persons with CRC and > 90% sensitivity for identifying persons with HRA, while improving colonoscopy specificity for ACNs by 23.8%. Our multivariable models show excellent discriminatory capacity for persons with ACNs and could significantly increase colonoscopy specificity without overly sacrificing sensitivity. If validated, these models could allow more efficient allocation of colonoscopy resources, potentially reducing wait times for those at higher risk while deferring unnecessary colonoscopies in low-risk individuals.

Sections du résumé

BACKGROUND BACKGROUND
Advanced colorectal neoplasms (ACNs), including colorectal cancers (CRC) and high-risk adenomas (HRA), are detected in less than 20% of persons aged 50 years or older who undergo colonoscopy. We sought to derive personalized predictive models of risk of harbouring ACNs to improve colonoscopy wait times for high-risk patients and allocation of colonoscopy resources.
METHODS METHODS
We characterized colonoscopy indications, neoplasia risk factors and colonoscopy findings through chart review for consecutive individuals aged 50 years or older who underwent outpatient colonoscopy at The Ottawa Hospital (Ottawa, Canada) between April 1, 2008 and March 31, 2012 for non-life threatening indications. We linked patients to population-level health administrative datasets to ascertain additional historical predictor variables and derive multivariable logistic regression models for risk of harboring ACNs at colonoscopy. We assessed model discriminatory capacity and calibration and the ability of the models to improve colonoscopy specificity while maintaining excellent sensitivity for ACN capture.
RESULTS RESULTS
We modelled 17 candidate predictors in 11,724 individuals who met eligibility criteria. The final CRC model comprised 8 variables and had a c-statistic value of 0.957 and a goodness-of-fit p-value of 0.527. Application of the models to our cohort permitted 100% sensitivity for identifying persons with CRC and > 90% sensitivity for identifying persons with HRA, while improving colonoscopy specificity for ACNs by 23.8%.
CONCLUSIONS CONCLUSIONS
Our multivariable models show excellent discriminatory capacity for persons with ACNs and could significantly increase colonoscopy specificity without overly sacrificing sensitivity. If validated, these models could allow more efficient allocation of colonoscopy resources, potentially reducing wait times for those at higher risk while deferring unnecessary colonoscopies in low-risk individuals.

Identifiants

pubmed: 34663234
doi: 10.1186/s12876-021-01965-5
pii: 10.1186/s12876-021-01965-5
pmc: PMC8524805
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

383

Informations de copyright

© 2021. The Author(s).

Références

Lancet. 2002 Jul 27;360(9329):278-83
pubmed: 12147370
Am J Epidemiol. 2012 Mar 15;175(6):584-93
pubmed: 22328705
Can J Gastroenterol. 2013 Apr;27(4):224-8
pubmed: 23616961
Br J Gen Pract. 2012 Jan;62(594):e29-37
pubmed: 22520670
JAMA. 2006 May 24;295(20):2366-73
pubmed: 16720822
Gut. 2012 Aug;61(8):1180-6
pubmed: 22110052
Gastroenterology. 2017 Jul;153(1):307-323
pubmed: 28600072
Gastroenterology. 2014 Mar;146(3):709-17
pubmed: 24012982
Can J Gastroenterol. 2013 Feb;27(2):83-9
pubmed: 23472243
J Clin Epidemiol. 2014 Aug;67(8):887-96
pubmed: 24774473
Am J Gastroenterol. 2016 Mar;111(3):355-65
pubmed: 26753884
J Clin Epidemiol. 1992 Jun;45(6):613-9
pubmed: 1607900
Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1043-51
pubmed: 23632815
Clin Gastroenterol Hepatol. 2009 Dec;7(12):1272-8
pubmed: 19523536
CMAJ Open. 2018 Aug 13;6(3):E330-E338
pubmed: 30104417
Eur Heart J. 2014 Aug 1;35(29):1925-31
pubmed: 24898551
Dis Colon Rectum. 1975 Sep;18(6):494-500
pubmed: 1181151
Gut. 2011 Sep;60(9):1236-41
pubmed: 21402615
BMC Gastroenterol. 2015 Nov 19;15:162
pubmed: 26585867
World J Gastroenterol. 2009 Mar 7;15(9):1085-92
pubmed: 19266601
Ann Intern Med. 2006 Dec 19;145(12):880-6
pubmed: 17179057
N Engl J Med. 2013 Sep 19;369(12):1095-105
pubmed: 24047059
Gastrointest Endosc. 2006 Nov;64(5):751-9
pubmed: 17055869
Pathologe. 2012 Nov;33 Suppl 2:206-10
pubmed: 22945585
N Engl J Med. 2014 Aug 28;371(9):799-807
pubmed: 25162886
Gut. 2011 Sep;60(9):1242-8
pubmed: 21357592
Gut. 2014 Jul;63(7):1112-9
pubmed: 24385598
Am J Gastroenterol. 2016 Aug;111(8):1092-101
pubmed: 27296945
Br J Cancer. 2009 Dec 3;101 Suppl 2:S80-6
pubmed: 19956169
J Gastroenterol Hepatol. 2014 Nov;29(11):1890-6
pubmed: 24909623

Auteurs

Sanjay K Murthy (SK)

Department of Medicine, University of Ottawa, Ottawa, Canada. smurthy@toh.ca.
Division of Gastroenterology, The Ottawa Hospital, Ottawa, Canada. smurthy@toh.ca.
Ottawa Hospital Research Institute, 501 Smyth Road, Unit W1212, Ottawa, ON, K1H 8L6, Canada. smurthy@toh.ca.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada. smurthy@toh.ca.

Lilia Antonova (L)

Ottawa Hospital Research Institute, 501 Smyth Road, Unit W1212, Ottawa, ON, K1H 8L6, Canada.

Catherine Dube (C)

Department of Medicine, University of Ottawa, Ottawa, Canada.
Division of Gastroenterology, The Ottawa Hospital, Ottawa, Canada.
Ottawa Hospital Research Institute, 501 Smyth Road, Unit W1212, Ottawa, ON, K1H 8L6, Canada.

Eric I Benchimol (EI)

Division of Gastroenterology, Hepatology and Nutrition, University of Toronto, Toronto, Canada.
The Hospital for Sick Children, Toronto, Canada.

Gregoire Le Gal (G)

Department of Medicine, University of Ottawa, Ottawa, Canada.
Ottawa Hospital Research Institute, 501 Smyth Road, Unit W1212, Ottawa, ON, K1H 8L6, Canada.

Richard Hae (R)

Department of Nephrology, McMaster University, Hamilton, Canada.

Stephen Burke (S)

Department of Family Medicine, University of Toronto, Toronto, Canada.

Tim Ramsay (T)

Ottawa Hospital Research Institute, 501 Smyth Road, Unit W1212, Ottawa, ON, K1H 8L6, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Alaa Rostom (A)

Department of Medicine, University of Ottawa, Ottawa, Canada.
Division of Gastroenterology, The Ottawa Hospital, Ottawa, Canada.
Ottawa Hospital Research Institute, 501 Smyth Road, Unit W1212, Ottawa, ON, K1H 8L6, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH